ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 938

Dermal Lymphatic Dysfunction and Photosensitivity in the MRL/Lpr Lupus Model

Noa Schwartz1, Susan Chyou2, Thomas Li3, William D. Shipman2,4,5 and Theresa T. Lu3, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Autoimmunity and Inflammation Program, Hospital for Special Surgery, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, 5Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Lymph node, skin and vasculogenesis, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S109 ACR Abstract: SLE–Animal Models (934–939)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Proper function of lymphatic vessels is needed to limit the magnitude and duration of tissue inflammation. Chronic inflammatory states such as obesity and psoriasis are associated with lymphatic dysfunction, but lymphatics in lupus models have not been well characterized. SLE patients are photosensitive, developing inflammatory skin lesions upon exposure to even ambient ultraviolet radiation (UVR). We hypothesized that lymphatic dysfunction may contribute to photosensitivity in lupus.

Methods: 8-10 week old MRL/MpJ-Faslpr/lpr (lpr) mice and age-/sex-matched MRL controls were evaluated at baseline, and after exposure to UVR. The source of UVR was a set of 4 FS40T12 sunlamps emitting UVA and UVB at 40:60 ratio. The overall dose of the total radiation ranged from 2000-2500 J/m2. Lymphatic function was assessed with an intradermal injection of 1µL of 2% evans blue (EB) to the ear, followed by measurement of EB concentration in the draining auricular lymph node (LN). Flow cytometry of ears and auricular LN allowed quantification of resident cell populations, and local mRNA expression of vascular endothelial growth factor-C (VEGF-C) was evaluated by real-time PCR. Mann-Whitney U test was used to compare the groups; data is presented as mean ± SE, with a two-tailed p-value of <0.05 considered significant.

Results: At baseline, auricular LNs of lpr mice are bigger and are about 10-fold more cellular than controls (21523860 ± 3861631 cells vs. 2184360 ± 464267 cells, respectively; p=0.008), but there is no compensatory increase in dermal lymphatic endothelial cells (LEC) to allow for an increase in local lymphatic transit to the LN (8918 ± 2142 LEC in lpr vs. 6106 ± 1023 LEC in controlsy; p=0.421). Accordingly, already at baseline, the effective flow of EB from the ear to the LN in lpr mice is only 44% that of controls, when accounting for the weight of the LN. Importantly, post-UVR, EB drainage in lpr mice is reduced to only 10% that of controls, and this value persists both 1 week after UVR and 1 month later. Interestingly, we have observed that at the peak of local inflammation that occurs at around 7 days post-UVR, VEGF-C mRNA levels are suppressed in both lpr and MRL strains, compared with non-UV exposed controls.

Conclusion: Dermal lymphatic network of lupus models have never been characterized, despite evidence for a major role of lymphatics in the regulation of chronic inflammation. Here we provide indications to impaired local lymphatic drainage in the lpr lupus strain, which can lead to reduced inhibitory signals arriving at the overactive lymph node from the lymphatic circulation, contributing to the unchecked inflammation known to occur in SLE. UVR is shown to further impair local lymphatics, particularly in the lupus strain, possibly through suppression of VEGF-C production.


Disclosure: N. Schwartz, None; S. Chyou, None; T. Li, None; W. D. Shipman, None; T. T. Lu, None.

To cite this abstract in AMA style:

Schwartz N, Chyou S, Li T, Shipman WD, Lu TT. Dermal Lymphatic Dysfunction and Photosensitivity in the MRL/Lpr Lupus Model [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/dermal-lymphatic-dysfunction-and-photosensitivity-in-the-mrl-lpr-lupus-model/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dermal-lymphatic-dysfunction-and-photosensitivity-in-the-mrl-lpr-lupus-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology